Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Published April 25, 2024
Citation Information: J Clin Invest. 2024;134(12):e176355. https://doi.org/10.1172/JCI176355.
View: Text | PDF
Research Article Cell biology Oncology Article has an altmetric score of 26

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer

  • Text
  • PDF
Abstract

Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase secretory pathway Ca2+ transporting 1 (ATP2C1). We show that GOLIM4 recruited ATP2C1 and Golgi phosphoprotein 3 (GOLPH3) to coordinate Ca2+-dependent cargo loading, Golgi membrane bending, and vesicle scission. GOLIM4 depletion disrupted the protein complex, resulting in a secretory blockade that inhibited the progression of 3q-amplified malignancies. In addition to its role as a scaffold, GOLIM4 maintained intracellular manganese (Mn) homeostasis by binding excess Mn in the Golgi lumen, which initiated the routing of Mn-bound GOLIM4 to lysosomes for degradation. We show that Mn treatment inhibited the progression of multiple types of 3q-amplified malignancies by degrading GOLIM4, resulting in a secretory blockade that interrupted prosurvival autocrine loops and attenuated prometastatic processes in the tumor microenvironment. As it potentially underlies the selective activity of Mn against 3q-amplified malignancies, ATP2C1 coamplification increased Mn influx into the Golgi lumen, resulting in a more rapid degradation of GOLIM4. These findings show that functional cooperativity between coamplified genes underlies heightened secretion and a targetable secretory addiction in 3q-amplified malignancies.

Authors

Xiaochao Tan, Shike Wang, Guan-Yu Xiao, Chao Wu, Xin Liu, Biyao Zhou, Yu Jiang, Dzifa Y. Duose, Yuanxin Xi, Jing Wang, Kunika Gupta, Apar Pataer, Jack A. Roth, Michael P. Kim, Fengju Chen, Chad J. Creighton, William K. Russell, Jonathan M. Kurie

×

Figure 1

Oncogenomic analysis of the 3q amplicon in human cancers.

Options: View larger image (or click on image) Download as PowerPoint
Oncogenomic analysis of the 3q amplicon in human cancers.
(A) Heatmap of...
(A) Heatmap of 3q-encoded gene copy numbers (y axis) in TCGA pan-cancer cohort (n = 589, x axis). Genomic regions are color-coded according to the copy number change and tumor type. hom., homozygous; het., heterozygous. (B and C) Somatic mutations (rows) in TCGA LUSC (B) and LUAD (C) cohorts (columns). (D) Correlation of GOLIM4 mRNA levels and gene copy numbers in TCGA LUSC samples (data points). Diploid, n = 50; gain, n = 238; amplification, n = 208. (E) GOLIM4 mRNA levels in normal lung tissues (NL) (n = 397), LUAD (n = 492), and LUSC (n = 488). (F) GOLIM4 mRNA levels in NL tissues (n = 3,691), primary lung tumors (n = 1,865), and distant metastases (n = 8) (https://tnmplot.com/). Box plots represent 33% (lower box) and 66% (upper box). P values were determined by Dunn’s test. (G and H) Kaplan-Meier survival analysis of TCGA pan-cancer cohort based on GOLIM4 copy numbers (G) and mRNA levels (H). (I) ddPCR assay of GOLIM4 copy numbers in NL tissues and 3q-amplified (Amp.) and -diploid LUSC tissues. Controls included 3q-amplified (H520) and -diploid (H23) cell lines. Data indicate the mean ± SD from a single experiment incorporating biological replicate samples (n = 3, unless otherwise indicated) and are representative of at least 2 independent experiments. ***P < 0.001 and ****P < 0.0001, by 1-way ANOVA (D–F) or log-rank test (G and H).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 4 news outlets
On 1 Facebook pages
2 readers on Mendeley
See more details